C-MER Eye Care Holdings Limited
Symbool: 3309.HK
HKSE
3.11
HKDMarktprijs vandaag
62.7191
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
3.87B
MRK Kapitalisatie
- 0.00%
DIV Rendement
C-MER Eye Care Holdings Limited (3309-HK) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 557.4 | 698.5 | 442.4 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 44.7 | 53.8 | 55.7 | ||||||||||
balance-sheet.row.net-receivables | 0 | 66.7 | 53.9 | 30.1 | ||||||||||
balance-sheet.row.inventory | 0 | 42 | 55.6 | 34.5 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 54.1 | 48.6 | 239.5 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 720.1 | 856.6 | 746.4 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1000.3 | 1057.6 | 901.3 | ||||||||||
balance-sheet.row.goodwill | 0 | 530.4 | 540.7 | 195 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 558.2 | 821.4 | 204 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1088.6 | 1362.1 | 398.9 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 193.1 | 129.2 | 77.4 | ||||||||||
balance-sheet.row.tax-assets | 0 | 6.8 | 6.9 | 11 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | -260.3 | -510.7 | -179.1 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 2028.5 | 2045.1 | 1209.5 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 2748.6 | 2901.7 | 1955.9 | ||||||||||
balance-sheet.row.account-payables | 0 | 54.9 | 45.3 | 39.9 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 116.5 | 149.3 | 265.5 | ||||||||||
balance-sheet.row.tax-payables | 0 | 24 | 18.9 | 8.5 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 13.8 | 21.2 | 7.6 | ||||||||||
Deferred Revenue Non Current | 0 | 232.7 | 281.9 | 198.6 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 163.7 | 290.7 | 92.2 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 366 | 378.6 | 210.4 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 232.7 | 281.9 | 198.6 | ||||||||||
balance-sheet.row.total-liab | 0 | 755.3 | 903.4 | 618.6 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 1520.5 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 125.6 | 126.7 | 115 | ||||||||||
balance-sheet.row.retained-earnings | 0 | 77.4 | 26.6 | 50.5 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -3.1 | 9.6 | 79 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 125.6 | 1703.2 | 1086.7 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1845.8 | 1866.1 | 1331.2 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2748.6 | 2901.7 | 1955.9 | ||||||||||
balance-sheet.row.minority-interest | 0 | 147.5 | 132.2 | 6 | ||||||||||
balance-sheet.row.total-equity | 0 | 1993.3 | 1998.2 | 1337.2 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 237.7 | 183 | 133.1 | ||||||||||
balance-sheet.row.total-debt | 0 | 363 | 452.5 | 471.7 | ||||||||||
balance-sheet.row.net-debt | 0 | -149.8 | -192.2 | 85 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 62 | -21.9 | 21.9 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 223.7 | 148.6 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -483.2 | -309.4 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 0.1 | 1.3 | 4.3 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -32.7 | -7.4 | ||||||||||
cash-flows.row.account-receivables | 0 | 0 | -26.7 | -18.5 | ||||||||||
cash-flows.row.inventory | 0 | 0 | -8.7 | -9.2 | ||||||||||
cash-flows.row.account-payables | 0 | 0 | 0.9 | 19.7 | ||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 1.7 | 0.6 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | -62.1 | 504.6 | 290.6 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -91.2 | -129.2 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | -80.3 | -223.5 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -39.2 | -40 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 106.7 | 277.6 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -106.7 | -277.6 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -210.7 | -392.7 | ||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -162 | -174.4 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 607.7 | 9.2 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -29.9 | -88.6 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -132.9 | -23 | ||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -1.2 | 354.9 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 281.6 | 78.1 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -4.8 | -1.1 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 258 | -167.3 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 644.7 | 644.7 | 386.7 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 644.7 | 386.7 | 553.9 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 191.9 | 148.4 | ||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -91.2 | -129.2 | ||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 100.6 | 19.2 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1924 | 1731.9 | 1112.6 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1381.5 | 1366.6 | 803.1 | ||||||||||
income-statement-row.row.gross-profit | 0 | 542.5 | 365.3 | 309.4 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | 5 | 0.6 | 0.3 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 426 | 389.8 | 311.8 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1807.5 | 1756.3 | 1114.9 | ||||||||||
income-statement-row.row.interest-income | 0 | 19.9 | 7.1 | 4.5 | ||||||||||
income-statement-row.row.interest-expense | 0 | 18.1 | 19.7 | 13 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 4.7 | -24.6 | 18.6 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | 5 | 0.6 | 0.3 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | 4.7 | -24.6 | 18.6 | ||||||||||
income-statement-row.row.interest-expense | 0 | 18.1 | 19.7 | 13 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 220.7 | 223.7 | 148.6 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | 116.4 | -24.4 | -2.3 | ||||||||||
income-statement-row.row.income-before-tax | 0 | 121.1 | -49 | 16.2 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 37.9 | 35 | 10.6 | ||||||||||
income-statement-row.row.net-income | 0 | 62 | -21.9 | 21.9 |
Vaak gestelde vragen
Wat is C-MER Eye Care Holdings Limited (3309.HK) totale activa?
C-MER Eye Care Holdings Limited (3309.HK) totale activa is 2748635000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.282.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.032.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.060.
Wat is C-MER Eye Care Holdings Limited (3309.HK) nettowinst (netto-inkomen)?
De nettowinst is 61998000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 362990000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 426032000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.